MetalloBio's mission is fundamentally to change the nature of antibiotics and the treatment of infections.
The coatings and additives business track promises nearer-term revenue through partnering with medical device companies. The partner company tests MetalloBio’s proprietary antibiotic-containing coatings in products such as catheters. MetalloBio is able to support innovation by providing combinations of novel Series 2 compounds presented in proprietary formulations, with partner companies responsible for further development, regulatory submissions, and commercialisation.